Phase I Single-blind Clinical Trial to Evaluate the Safety and Local Immune Activation of a Toll-like Receptor 5 Agonist (FLAMOD) Administered by Aerosol

NCT06681402 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pneumonia

Interventions

DRUG: FLAMOD
DRUG: Placebo

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Collaborators

[object Object]